- Conditions
- Colitis, Colitis, Ulcerative, Inflammatory Bowel Diseases, Ulcerative Colitis
- Interventions
- Placebo, SPY001, SPY002, SPY003
- Other · Drug
- Lead sponsor
- Spyre Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 645 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 27
- States / cities
- Canoga Park, California • La Jolla, California • Lancaster, California + 24 more
Clinical trials in Chicago, Illinois
This page shows live ClinicalTrials.gov search results for Chicago, Illinois, with direct links to official study records plus on-page filtering and sorting for broad location searches.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.
Institutions in Chicago
Campus pages list official records that name the campus as a study site. Listed in directory order, not ranked.
Stored official records
Open in full search- Conditions
- Ulcerative Colitis
- Interventions
- RO7837195, RO7837195 Matched Placebo
- Drug
- Lead sponsor
- Genentech, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 224 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 9
- States / cities
- Lancaster, California • San Diego, California • Colorado Springs, Colorado + 6 more
- Conditions
- Chronic Hepatitis D Infection
- Interventions
- Brelovitug 300 mg, Brelovitug 900 mg, Delayed Treatment with Brelovitug 300mg
- Drug
- Lead sponsor
- Mirum Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 10
- States / cities
- Long Beach, California • Los Angeles, California • Chicago, Illinois + 4 more
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Bevacizumab, Fluorouracil, Leucovorin, Oxaliplatin, Panitumumab, Telisotuzumab Adizutecan
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 390 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 17
- States / cities
- Duarte, California • Santa Monica, California • New Haven, Connecticut + 14 more
- Conditions
- Nocturia, Overactive Bladder (OAB), Urinary Frequency, Urinary Urge Incontinence (UUI), Urinary Urgency
- Interventions
- AUGS Patient Handouts, RiSolve App
- Behavioral · Device
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 22 Years and older · Female only
- Enrollment
- 596 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • Palo Alto, California • Washington D.C., District of Columbia + 7 more
- Conditions
- Neovascular Age-related Macular Degeneration (nAMD)
- Interventions
- Faricimab
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 274 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 11
- States / cities
- Santa Ana, California • Orlando, Florida • Winter Haven, Florida + 8 more
- Conditions
- Dravet Syndrome
- Interventions
- LP352, Placebo
- Drug
- Lead sponsor
- Longboard Pharmaceuticals
- Industry
- Eligibility
- 2 Years to 65 Years
- Enrollment
- 108 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 25
- States / cities
- Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 20 more
- Conditions
- Gastrointestinal Stromal Cancer, Gastrointestinal Stromal Cell Tumors, Gastrointestinal Stromal Neoplasm, Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Tumor, Malignant
- Interventions
- imatinib mesylate, ziftomenib
- Drug
- Lead sponsor
- Kura Oncology, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 135 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • La Jolla, California + 26 more
- Conditions
- Economic Problems, Firearm Injury, Injury Traumatic
- Interventions
- HVIP Standard of Care, Recovery Legal Care
- Other
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 14 Years and older
- Enrollment
- 202 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma
- Interventions
- ALN-BCAT, Pembrolizumab
- Drug
- Lead sponsor
- Alnylam Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 16
- States / cities
- Phoenix, Arizona • La Jolla, California • Los Angeles, California + 12 more
- Conditions
- Major Depressive Disorder
- Interventions
- CYB003, Placebo, Psychological Support
- Drug · Behavioral
- Lead sponsor
- Cybin IRL Limited
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 223 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 45
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Bellflower, California + 35 more
- Conditions
- Gestational Hypertension, Hypertensive Disorders of Pregnancy, Preeclampsia
- Interventions
- Aspirin 162 mg, Aspirin 81 mg
- Drug
- Lead sponsor
- Ohio State University
- Other
- Eligibility
- 14 Years to 35 Years · Female only
- Enrollment
- 10,742 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 20
- States / cities
- Birmingham, Alabama • Los Angeles, California • San Francisco, California + 16 more